Screening of inhibitors for S130G inhibitor resistant mutants of TEM type beta-lactamase

被引:6
作者
Baig, Mohd Hassan [1 ]
Danishuddin, Mohd [2 ]
Khan, Saif [1 ]
Khan, Asad U. [2 ]
机构
[1] Integral Univ, Dept Biotechnol Microbiol & Bioinformat, Lucknow 226026, Uttar Pradesh, India
[2] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India
关键词
D O I
10.6026/97320630081225
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Bacteria are remarkably adaptable organisms that acquire an almost limitless competence to survive under unpleasant conditions. The drastic emergence of antibiotic resistance among beta-Lactamases is the most serious threat to hospitals and nosocomial settings. beta-lactam inhibitors came into existence in order to overcome the problem of antibibiotic resistance in bacteria. The emergence of inhibitor resistant mutants has raised the alarms. In this study we have used structured based virtual screening approach and have screened out some inhibitors against S130G TEM mutant. All the compounds were tested in presence and absence of conserved active site water molecules. These compounds were found be showing much higher efficacy than known beta-lactamase inhibitors. Amino acids G130, S70, N132, G130, Y105 and V216 were found crucial for the interaction of inhibitors within the active site.
引用
收藏
页码:1225 / 1229
页数:5
相关论文
共 29 条
  • [1] Protonation of the β-lactam nitrogen is the trigger event in the catalytic action of class A β-lactamases
    Atanasov, BP
    Mustafi, D
    Makinen, MW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3160 - 3165
  • [2] Inhibition of OXA-1 β-lactamase by penems
    Bethel, Christopher R.
    Distler, Anne M.
    Ruszczycky, Mark W.
    Carey, Marianne P.
    Carey, Paul R.
    Hujer, Andrea M.
    Taracila, Magda
    Helfand, Marion S.
    Thomson, Jodi M.
    Kalp, Matthew
    Anderson, Vernon E.
    Leonard, David A.
    Hujer, Kristine M.
    Abe, Takao
    Venkatesan, Aranapakam M.
    Mansour, Tarek S.
    Bonomo, Robert A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (09) : 3135 - 3143
  • [3] Brasseur J. L., 1991, BIOCHEM J, V279, P213
  • [4] CHARMM: The Biomolecular Simulation Program
    Brooks, B. R.
    Brooks, C. L., III
    Mackerell, A. D., Jr.
    Nilsson, L.
    Petrella, R. J.
    Roux, B.
    Won, Y.
    Archontis, G.
    Bartels, C.
    Boresch, S.
    Caflisch, A.
    Caves, L.
    Cui, Q.
    Dinner, A. R.
    Feig, M.
    Fischer, S.
    Gao, J.
    Hodoscek, M.
    Im, W.
    Kuczera, K.
    Lazaridis, T.
    Ma, J.
    Ovchinnikov, V.
    Paci, E.
    Pastor, R. W.
    Post, C. B.
    Pu, J. Z.
    Schaefer, M.
    Tidor, B.
    Venable, R. M.
    Woodcock, H. L.
    Wu, X.
    Yang, W.
    York, D. M.
    Karplus, M.
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2009, 30 (10) : 1545 - 1614
  • [5] BUSH K, 1988, Clinical Microbiology Reviews, V1, P109
  • [6] Updated Functional Classification of β-Lactamases
    Bush, Karen
    Jacoby, George A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) : 969 - 976
  • [7] New β-lactam antibiotics and β-lactamase inhibitors
    Bush, Karen
    Macielag, Mark J.
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (10) : 1277 - 1293
  • [8] IRT and CMT β-lactamases and inhibitor resistance
    Canton, R.
    Morosini, M. I.
    Martin, O.
    de la Maza, S.
    de la Pedrosa, E. Gomez G.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 53 - 62
  • [9] PENICILLINASE SYNTHESIS CONTROLLED BY INFECTIOUS R FACTORS IN ENTEROBACTERIACEAE
    DATTA, N
    KONTOMICHALOU, P
    [J]. NATURE, 1965, 208 (5007) : 239 - +
  • [10] High tolerance to simultaneous active-site mutations in TEM-1 β-lactamase: Distinct mutational paths provide more generalized β-lactam recognition
    De Wals, Pierre-Yves
    Doucet, Nicolas
    Pelletier, Joelle N.
    [J]. PROTEIN SCIENCE, 2009, 18 (01) : 147 - 160